# An Update on Machine Learning in Neuro-oncology Diagnostics

arXiv: https://arxiv.org/abs/1910.08157 · HTML: https://mlsanity.com/paper/1910.08157/

## Key facts

- Cited by 1 papers in the map (data through 14 Oct 2026).
- First posted on arXiv 9 Aug 2019.

## Built on by (most cited first, 1 of 1)

- [Machine Learning and Glioblastoma: Treatment Response Monitoring Biomarkers in 2021](https://mlsanity.com/paper/2104.08072/) (2021)

## Abstract (arXiv)

Imaging biomarkers in neuro-oncology are used for diagnosis, prognosis and treatment response monitoring. Magnetic resonance imaging is typically used throughout the patient pathway because routine structural imaging provides detailed anatomical and pathological information and advanced techniques provide additional physiological detail. Following image feature extraction, machine learning allows accurate classification in a variety of scenarios. Machine learning also enables image feature extraction de novo although the low prevalence of brain tumours makes such approaches challenging. Much research is applied to determining molecular profiles, histological tumour grade and prognosis at the time that patients first present with a brain tumour. Following treatment, differentiating a treatment response from a post-treatment related effect is clinically important and also an area of study. Most of the evidence is low level having been obtained retrospectively and in single centres.